Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages

References

• WHO. Human Papillomavirus. Available from: www.who.int/vaccines/en/hpvrd.shtml [Last accessed 30 December 2013]
   Google Scholar
• CDC. Human Papillomavirus (HPV). Available from: http://www.cdc.gov/hpv [Last accessed 30 December 2013]
   Google Scholar
• Moscicki AB. Impact of HPV infection in adolescent populations. J Adolesc Health 2005;37(Suppl 6):s3-9
   PubMed Web of Science ®Google Scholar
• Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-19
   PubMed Web of Science ®Google Scholar
• Zur Hausen H. Human genital cancer: synergism between two virus infections and or synergism between a virus infection and initiating events? Lancet 1982;2:1370-2
   PubMed Web of Science ®Google Scholar
• Dürst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 1983;80(12):3812-15
   PubMed Web of Science ®Google Scholar
• Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64
   PubMed Web of Science ®Google Scholar
• Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802
   PubMed Web of Science ®Google Scholar
• Muñoz N, Bosch X, De SanJosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;3248:518-27
   Google Scholar
• Smith JS, Backes DM, Hoots BE, et al. Human papilloma virus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 2009;113:917-24
   PubMed Web of Science ®Google Scholar
• Hoots BE, Palefsky JM, Pimenta JM, et al. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009;124:2375-83
   PubMed Web of Science ®Google Scholar
• Backes DM, Kurman R, Pimenta JM, et al. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 2009;20:449-57
   PubMed Web of Science ®Google Scholar
• Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20
   PubMed Web of Science ®Google Scholar
• Cogliano V, Baan R, Straif K, et al. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005;6:204
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294-301
   PubMed Web of Science ®Google Scholar
• Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119:2620-3
   PubMed Web of Science ®Google Scholar
• Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110:1429-35
   PubMed Web of Science ®Google Scholar
• D’Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56
   PubMed Web of Science ®Google Scholar
• Bouvard V, Baan R, Straif K, et al. A review of human carcinogens. Part B: biological agents. Lancet Oncol 2009;10:321-2
   PubMed Web of Science ®Google Scholar
• Kreimer A, Bhatia R, Messeguer A, et al. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010;37:386-91
   PubMed Web of Science ®Google Scholar
• Gillison ML, Alemany L, Snijders PJ, et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine 2012;30:Suppl. 5):F34-54
   PubMedGoogle Scholar
• Beachler DC, D’Souza G. Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol 2013;25:503-10
   Google Scholar
• Osazuwa-Peters N. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States-Do we need a broader vaccine policy? Vaccine 2013;31:5500-5
   PubMedGoogle Scholar
• Chung CH, Bagheri A, D’Souza G. Epidemiology of oral human papillomavirus infection. Oral Oncol 2014;50(5):364-9
   PubMed Web of Science ®Google Scholar
• Boscolo-Rizzo P, Del Mistro A, Bussu F, et al. New insights into human papillomavirus-associated head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital 2013;33:77-87
   PubMedGoogle Scholar
• Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-75
   PubMed Web of Science ®Google Scholar
• IARC monographs on the evaluation of carcinogenic risks to humans (World Health Organization). Biological agents, Volume 100 B: a review of human carcinogens. International Agency for Research on Cancer Lyon, France: 2012;255-313. Available from: www.monographs.iarc.fr/ENG/Monographs/vol100B/mono100B.pdf
   Google Scholar
• Hasegawa M, Deng Z, Maeda H, et al. Human papillomavirus load and physical status in sinonasal inverted papilloma and squamous cell carcinoma. Rhinology 2012;50:87-94
   PubMed Web of Science ®Google Scholar
• Govindaraj S, Wang H. Does human papilloma virus play a role in sinonasal inverted papilloma? Curr Opin Otolaryngol Head Neck Surg 2013
   PubMedGoogle Scholar
• Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45:309-16
   PubMed Web of Science ®Google Scholar
• Garner EI. Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev 2003;12:242s-7s
   PubMed Web of Science ®Google Scholar
• Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009;4:8
   PubMedGoogle Scholar
• Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms. J Natl Compr Canc Netw 2011;9:665-73
   PubMed Web of Science ®Google Scholar
• Ryerson AB, Peters ES, Coughlin SS, et al. Burden of potentially human papillomavirus-associated cancers of theoropharynx and oral cavity in the US. 1998Cancer 2008;113(Suppl 10):2901-9
   Google Scholar
• Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009;125:362-6
   PubMed Web of Science ®Google Scholar
• Hong AM, Grulich AE, Jones D, et al. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 2010;28:3269-72
   PubMed Web of Science ®Google Scholar
• Jemal A, Simard EP, Dorell C, et al. Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013;105:175-201
   PubMed Web of Science ®Google Scholar
• Rodrigo JP, Heideman DA, García-Pedrero JM, et al. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009). Int J Cancer 2014;134(2):487-92
   PubMedGoogle Scholar
• Rietbergen MM, Leemans CR, Bloemena E, et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cellcarcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 2013;132:1565-71
   PubMed Web of Science ®Google Scholar
• Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 1995;33:2058-63
   Google Scholar
• Gissmann L, Diehl V, Schultz-Coulon HJ, et al. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol 1982;44:393-400
   PubMed Web of Science ®Google Scholar
• Major T, Szarka K, Sziklai I, et al. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol 2005;58:51-5
   PubMed Web of Science ®Google Scholar
• Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006;24(Suppl 3):35-41
   Google Scholar
• Gerein V, Rastorguev E, Gerein J, et al. Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience. Otolaryngol Head Neck Surg 2005;132:392-4
   PubMedGoogle Scholar
• Dedo HH, Yu KC. CO(2) laser treatment in 244 patients with respiratory papillomas. Laryngoscope 2001;111:1639-44
   PubMed Web of Science ®Google Scholar
• Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012;307:693-703
   PubMed Web of Science ®Google Scholar
• Pickard RK, Xiao W, Broutian TR, et al. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 2012;39:559-66
   PubMed Web of Science ®Google Scholar
• Edelstein ZR, Schwartz SM, Hawes S, et al. Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis 2012;39:860-7
   PubMed Web of Science ®Google Scholar
• D’Souza G, Agrawal Y, Halpern J, et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009;199:1263-9
   PubMed Web of Science ®Google Scholar
• Smith EM, Swarnavel S, Ritchie JM, et al. Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J 2007;26:836-40
   PubMed Web of Science ®Google Scholar
• Summersgill KF, Smith EM, Levy BT, et al. Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:62-9
   PubMed Web of Science ®Google Scholar
• Kreimer AR, Campbell CMP, Lin HY, et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet 2013;382:877-87
   PubMed Web of Science ®Google Scholar
• Burchell AN, Winer RL, de Sanjosé S, et al. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006;24:Suppl 3):S52-61
   Web of Science ®Google Scholar
• Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24(Suppl 1):S1-15
   PubMed Web of Science ®Google Scholar
• de Sanjosé S, Díaz M, Castellsagué X, et al. Worldwide prevalence and type distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007;7:453-9
   PubMed Web of Science ®Google Scholar
• Panatto D, Amicizia D, Tanzi E, et al. Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? BMC Infect Dis 2013;13:575
   PubMed Web of Science ®Google Scholar
• Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States the national health and nutrition examination survey, 2003–2006. J Infect Dis 2011;204:566-73
   PubMed Web of Science ®Google Scholar
• Moscicki AB, Ellenberg JH, Farhat S, et al. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis 2004;190:37-45
   PubMed Web of Science ®Google Scholar
• Denny LA, Sankaranarayanan R, De Vuyst H, et al. Recommendations for cervical cancer prevention in sub-saharan Africa. Vaccine 2013;31(Suppl 5):F73-4
   Google Scholar
• Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001;183:383-91
   PubMed Web of Science ®Google Scholar
• Olesen TB, Iftner T, Mwaiselage J, et al. Prevalence and type distribution of human papillomavirus among 1813 men in Tanzania and the relationship to HIV status. Sex Transm Dis 2013;40:592-8
   PubMedGoogle Scholar
• Nyitray AG, Carvalho da Silva RJ, Baggio ML, et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 2011;204:1711-22
   PubMed Web of Science ®Google Scholar
• Goodman MT, Shvetsov YB, McDuffie K, et al. Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study. J Infect Dis 2008;197:957-66
   PubMed Web of Science ®Google Scholar
• Videla S, Darwich L, Canadas MP, et al. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men. Sex Transm Dis 2013;40:3-10
   PubMed Web of Science ®Google Scholar
• Nyitray AG, Smith D, Villa L, et al. Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study. J Infect Dis 2010;201:1498-508
   PubMed Web of Science ®Google Scholar
• Bruni L, Díaz M, Castellsagué X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010;202:1789-99
   PubMed Web of Science ®Google Scholar
• Kero K, Rautava J, Syrjänen K, et al. Oral mucosa as a reservoir of human papillomavirus: point prevalence, type distribution, and incident infections among males in a 7-year prospective study. Eur Urol 2012;62:1063-70
   PubMed Web of Science ®Google Scholar
• Coutlee F, Trottier AM, Ghattas G, et al. Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex Transm Dis 1997;24:23-31
   PubMedGoogle Scholar
• Kreimer AR, Alberg AJ, Daniel R, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004;189:686-98
   PubMed Web of Science ®Google Scholar
• Cameron JE, Mercante D, O’Brien M, et al. The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults. Sex Transm Dis 2005;32:703-9
   PubMedGoogle Scholar
• Marais DJ, Passmore JA, Denny L, et al. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa. J Med Virol 2008;80:953-9
   PubMed Web of Science ®Google Scholar
• Richter KL, van Rensburg EJ, van Heerden WF, Boy SC. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy. J Oral Pathol Med 2008;37:555-9
   PubMed Web of Science ®Google Scholar
• Fakhry C, Sugar E, D’Souza G, Gillison M. Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort. PLoS One 2010;5:e11918
   Google Scholar
• Parisi SG, Cruciani M, Scaggiante R, et al. Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. BMC Infect Dis 2011;11:150
   PubMed Web of Science ®Google Scholar
• Read TR, Hocking JS, Vodstrcil LA, et al. Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS One 2012;7:e49324
   PubMed Web of Science ®Google Scholar
• Del Mistro A, Baboci L, Frayle-Salamanca H, et al. Oral human papillomavirus and human herpesvirus-8 infections among human immunodeficiency virus type 1-infected men and women in Italy. Sex Transm Dis 2012;39:894-8
   PubMed Web of Science ®Google Scholar
• Steinau M, Reddy D, Sumbry A, et al. Oral sampling and human papillomavirus genotyping in HIV-infected patients. J Oral Pathol Med 2012;41:288-91
   PubMed Web of Science ®Google Scholar
• Fatahzadeh M, Schlecht NF, Chen Z, et al. Oral human papillomavirus detection in older adults who have human immunodeficiency virus infection. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115:505-14
   PubMedGoogle Scholar
• Beachler DC, Weber KM, Margolick JB, et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev 2012;21:122-33
   PubMed Web of Science ®Google Scholar
• Darwich L, Cañadas MP, Videla S, et al. Oral human papillomavirus type-specific infection in HIV-infected men: a prospective cohort study among men who have sex with men and heterosexual men. Clin Microbiol Infect 2013. [Epub ahead of print]
   PubMedGoogle Scholar
• Beachler DC, D’Souza G, Sugar EA, et al. Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis 2013;208:330-9
   PubMed Web of Science ®Google Scholar
• Flores R, Lu B, Nielson C, et al. Correlates of human papillomavirus viral load with infection site in asymptomatic men. Cancer Epidemiol Biomarkers Prev 2008;17:3573-6
   PubMedGoogle Scholar
• Dunne EF, Nielson CM, Stone KM, et al. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006;194:1044-57
   PubMed Web of Science ®Google Scholar
• Bleeker MCG, Hogewoning CJA, Berkhof J, et al. Concordance of specifi human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005;41:612-20
   PubMed Web of Science ®Google Scholar
• Schmitt M, Depuydt C, Benoy I, et al. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol 2013;51:1458-64
   PubMed Web of Science ®Google Scholar
• Snijders PJ, Hogewoning CJ, Hesselink AT, et al. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology. Int J Cancer 2006;119:1102-7
   PubMed Web of Science ®Google Scholar
• Rintala M, Grénman S, Puranen M, et al. Natural history of oral papillomavirus infections in spouses: a prospective Finnish HPV Family Study. J Clin Virol 2006;35:89-94
   PubMed Web of Science ®Google Scholar
• Koskimaa HM, Waterboer T, Pawlita M, et al. Human papillomavirus types present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus types. J Pediatr 2011;160:837-43
   PubMedGoogle Scholar
• Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612-19
   PubMed Web of Science ®Google Scholar
• Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and non-oropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2013;35:747-55
   PubMed Web of Science ®Google Scholar
• Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the US population ages 20-44 years. Cancer 2005;103:1843-9
   PubMed Web of Science ®Google Scholar
• Colevas AD. Population-based evaluation of incidence trends in oropharyngeal cancer focusing on socioeconomic status, sex, and race/ethnicity. Head Neck 2014;36:34-42
   PubMed Web of Science ®Google Scholar
• Hocking JS, Stein A, Conway EL, et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 2011;104:886-91
   PubMed Web of Science ®Google Scholar
• Auluck A, Hislop G, Bajdik C, et al. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 2010;116:2635-44
   PubMed Web of Science ®Google Scholar
• Blomberg M, Nielsen A, Munk C, Kjaer SK. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. Int J Cancer 2011;129:733-41
   PubMed Web of Science ®Google Scholar
• Reddy VM, Cundall-Curry D, Bridger MW. Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985-2006. Ann R Coll Surg Engl 2010;92:655-9
   PubMedGoogle Scholar
• Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004;57:449-55
   PubMed Web of Science ®Google Scholar
• Ioka A, Tsukuma H, Ajiki W, et al. Trends in head and neck cancer incidence in Japan during 1965-1999. Jpn J Clin Oncol 2005;35:45-7
   PubMedGoogle Scholar
• Braakhuis BJ, Visser O, Leemans CR. Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults. Oral Oncol 2009;45:e85-9
   PubMed Web of Science ®Google Scholar
• Mork J, Moller B, Dahl T, et al. Time trends in pharyngeal cancer incidence in Norway 1981-2005: a subsite analysis based on a reabstraction and recoding of registered cases. Cancer Causes Control 2010;21:1397-405
   PubMed Web of Science ®Google Scholar
• Robinson KL, Macfarlane GJ. Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing? Oral Oncol 2003;39:31-6
   PubMedGoogle Scholar
• Marur S, D’Souza G, Westra WH, et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010;11:781-9
   PubMed Web of Science ®Google Scholar
• Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008;26:Suppl 10):K1-16
   PubMed Web of Science ®Google Scholar
• Kjaer SK, Chackerian B, van den Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001;10:101-6
   PubMed Web of Science ®Google Scholar
• Hwang LY, Ma Y, Benningfield SM, et al. Factors that influence the rate of epithelial maturation in the cervix in healthy young women. J Adolesc Health 2009;44:103-10
   PubMedGoogle Scholar
• Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180:1415-23
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women’s Health Study. J Infect Dis 2002;186:462-9
   PubMed Web of Science ®Google Scholar
• Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8
   PubMed Web of Science ®Google Scholar
• Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003;12:485-90
   PubMed Web of Science ®Google Scholar
• Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Lee JH, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011;377:932-40
   PubMed Web of Science ®Google Scholar
• Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012;13:487-500
   PubMed Web of Science ®Google Scholar
• Howard JD, Chung CH. Biology of human papillomavirus-related oropharyngeal cancer. Semin Radiat Oncol 2012;22:187-93
   PubMedGoogle Scholar
• Pai SI, Westra WH. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol 2009;4:49-70
   PubMed Web of Science ®Google Scholar
• Fakhry C, Marks MA, Gilman RH, et al. Comparison of the immune microenvironment of the oral cavity and cervix in healthy women. Cytokine 2013;64:597-604
   PubMed Web of Science ®Google Scholar
• Beachler DC, D’Souza G. Natural history of oral papillomavirus infection in men. Lancet 2013;382:839-41
   PubMedGoogle Scholar
• Brown DR, Kjaer SK, Sigurdsson K, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16–26 years. J Infect Dis 2009;199:926-35
   PubMed Web of Science ®Google Scholar
• De Carvalho N, Teixeira J, Roteli-Martins CM, et al. Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women. Vaccine 2010;28:6247-55
   PubMed Web of Science ®Google Scholar
• FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-27
   PubMed Web of Science ®Google Scholar
• Paavonen J, Naud P, Salmeron J, et al. Effi cacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301-14
   PubMed Web of Science ®Google Scholar
• Herrero R, Quint W, Hildesheim A, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination. PLoS One 2013;8:e68329
   PubMed Web of Science ®Google Scholar
• Villa LL. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases. Vaccine 2006;24:23-8
   Google Scholar
• Fakhry C, Rosenthal BT, Clark DP, Gillison ML. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal “pap-test equivalent” in high-risk populations. Cancer Prev Res (Phila) 2011;4:1378-84
   PubMed Web of Science ®Google Scholar
• Schiffman M, Solomon D. Cervical-cancer screening with human papillomavirus and cytologic cotesting. N Engl J Med 2013;369:2324-31
   PubMedGoogle Scholar
• Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007;7:11-22
   PubMed Web of Science ®Google Scholar
• Akers AY, Newmann SJ, Smith JS. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 2007;31:157-81
   PubMedGoogle Scholar
• Arbyn M, Anttila A, Jordan J, et al. European guidelines for quality assurance in cervical cancer screening-summary document. Ann Oncol 2010;21:448-58
   PubMed Web of Science ®Google Scholar
• Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004;31:744-54
   PubMed Web of Science ®Google Scholar
• Westra WH. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 2009;3:78-81
   PubMedGoogle Scholar
• Lingen MW, Kalmar JR, Karrison T, et al. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008;44:10-22
   PubMed Web of Science ®Google Scholar
• Wetzel C, Tissot A, Kollar LM, et al. Development of an HPV educational protocol for adolescents. J Pediatr Adolesc Gynecol 2007;20:281-7
   PubMed Web of Science ®Google Scholar
• Reiter PL, Stubbs B, Panozzo CA, et al. HPV and HPV vaccine education intervention: effects on parents, healthcare staff, and school staff. Cancer Epidemiol Biomarkers Prev 2011;20:2354-61
   PubMed Web of Science ®Google Scholar
• Davis K, Dickman ED, Ferris D, et al. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004;8:188-94
   PubMedGoogle Scholar